KR20020015704A - 인테그린 α브이β6의 저해제 - Google Patents

인테그린 α브이β6의 저해제 Download PDF

Info

Publication number
KR20020015704A
KR20020015704A KR1020017016580A KR20017016580A KR20020015704A KR 20020015704 A KR20020015704 A KR 20020015704A KR 1020017016580 A KR1020017016580 A KR 1020017016580A KR 20017016580 A KR20017016580 A KR 20017016580A KR 20020015704 A KR20020015704 A KR 20020015704A
Authority
KR
South Korea
Prior art keywords
asp
leu
arg
ser
thr
Prior art date
Application number
KR1020017016580A
Other languages
English (en)
Korean (ko)
Inventor
존크지크알프레트
디펜바흐베아테
그로트울리히
지친스키군테르
Original Assignee
플레믹 크리스티안
메르크 파텐트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 플레믹 크리스티안, 메르크 파텐트 게엠베하 filed Critical 플레믹 크리스티안
Publication of KR20020015704A publication Critical patent/KR20020015704A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020017016580A 1999-06-26 2000-06-13 인테그린 α브이β6의 저해제 KR20020015704A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19929410A DE19929410A1 (de) 1999-06-26 1999-06-26 Inhibitoren des Integrins avß6
DE19929410.0 1999-06-26
PCT/EP2000/005404 WO2001000660A1 (de) 1999-06-26 2000-06-13 INHIBITOREN DES INTEGRINS αv$(g)b¿6?

Publications (1)

Publication Number Publication Date
KR20020015704A true KR20020015704A (ko) 2002-02-28

Family

ID=7912712

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017016580A KR20020015704A (ko) 1999-06-26 2000-06-13 인테그린 α브이β6의 저해제

Country Status (17)

Country Link
EP (1) EP1189930A1 (cs)
JP (1) JP2003503422A (cs)
KR (1) KR20020015704A (cs)
CN (1) CN1358195A (cs)
AR (1) AR024472A1 (cs)
AU (1) AU771099B2 (cs)
BR (1) BR0011954A (cs)
CA (1) CA2377224A1 (cs)
CZ (1) CZ20014484A3 (cs)
DE (1) DE19929410A1 (cs)
HU (1) HUP0201729A3 (cs)
MX (1) MXPA01013247A (cs)
NO (1) NO20016341L (cs)
PL (1) PL352374A1 (cs)
SK (1) SK18722001A3 (cs)
WO (1) WO2001000660A1 (cs)
ZA (1) ZA200200673B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
JP2007523835A (ja) 2003-02-06 2007-08-23 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ペプチドスルホンアミド
GB0520068D0 (en) * 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
ES2746925T3 (es) 2006-08-03 2020-03-09 Medimmune Ltd Anticuerpos dirigidos hacia alfaVbeta6 y uso de los mismos
ES2906109T3 (es) 2016-11-01 2022-04-13 Arrowhead Pharmaceuticals Inc Ligandos de la integrina alfa- v beta-6 y usos de los mismos
EP3703700A4 (en) 2017-11-01 2021-08-04 Arrowhead Pharmaceuticals, Inc. INTEGRIN LIGANDS AND USES THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2103139A1 (en) * 1991-05-14 1992-11-15 George A. Heavner Peptide inhibitors of inflammation
ATE511850T1 (de) * 1997-08-08 2011-06-15 Univ California Behandlung von blasenfibrose mit antikörpern gegen alpha-v-beta-6-integrin
CZ20012212A3 (cs) * 1998-12-19 2001-09-12 Merck Patent Gmbh Peptidická sloučenina, její použití a farmaceutický prostředek, který ji obsahuje

Also Published As

Publication number Publication date
NO20016341D0 (no) 2001-12-21
PL352374A1 (en) 2003-08-25
BR0011954A (pt) 2002-05-07
EP1189930A1 (de) 2002-03-27
CN1358195A (zh) 2002-07-10
CA2377224A1 (en) 2001-01-04
MXPA01013247A (es) 2002-07-02
CZ20014484A3 (cs) 2002-04-17
SK18722001A3 (sk) 2002-05-09
AU6263000A (en) 2001-01-31
DE19929410A1 (de) 2000-12-28
HUP0201729A2 (en) 2002-08-28
HUP0201729A3 (en) 2005-01-28
AU771099B2 (en) 2004-03-11
WO2001000660A1 (de) 2001-01-04
AR024472A1 (es) 2002-10-02
NO20016341L (no) 2002-02-25
ZA200200673B (en) 2003-04-24
JP2003503422A (ja) 2003-01-28

Similar Documents

Publication Publication Date Title
US6001961A (en) Cyclic adhesion inhibitors
MXPA96004100A (en) Cyclic compounds, adhes inhibitors
AU772782B2 (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
BG65065B1 (bg) Пептидни антиангиогенни лекарствени средства
JP4115530B2 (ja) 環状接着阻害剤
CA2355874A1 (en) .alpha.v.beta.6 integrin inhibitors
JPH06321988A (ja) 新規直鎖状ペプチド
KR20020015704A (ko) 인테그린 α브이β6의 저해제
US5747457A (en) Linear adhesion inhibitors
JP4127325B2 (ja) ビオチン誘導体
AU770295B2 (en) AlphaVbetaB integrin inhibitors
MXPA01006229A (en) &agr;v

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid